AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
18 hedge funds and large institutions have $40.7M invested in Ambrx Biopharma Inc in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Holders
18
Holding in Top 10
1
Calls
$61K
Puts
$233K
Top Buyers
| 1 | +$17.2M | |
| 2 | +$106K | |
| 3 | +$45.4K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$41.5K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$40.6K |
Top Sellers
| 1 | -$3.08M | |
| 2 | -$2.27M | |
| 3 | -$2.03M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$1.61M |
| 5 |
Millennium Management
New York
|
-$217K |